ESOT Grants Recipients
The Transplant Fellowship Grants are partially supported by Roche with unrestricted funding. The Company is not involved in any way, directly and indirectly, in the assignment process.
Mr David Schibilsky M.D.Hospital/Company: Papworth Hospital NHS TrustOffice City: Papworth - CambridgeshireOffice Country: United KingdomPERSONAL DETAILS Date/Place of Birth 25th July 1981 / Duisburg, Germany EDUCATION March 2016 - present: Cardiothoracic Surgeon, University Heart Center Tübingen March 2016: Board Certification Cardiac Surgery, Karlsruhe/Reutlingen, Germany June 2011 – March 2016: Resident in Thoracic and Cardiovascular Surgery, University Heart Center, Tübingen (Prof. Schlensak), Germany April/May 2013Research Fellowship: Cardiovascular Surgery, DeBakey Heart and Vascular Center, Houston, Texas, USA (ISHLT travel scholarship) November 2011 Clinical Fellowship (MCS): Cardiovascular Surgery, Heart-Center Bad Oeyenhausen, Germany October 2009 – May 2011Resident in Cardiovascular Surgery, University Heart Center Freiburg – Bad Krozingen (Prof. Beyersdorf), Germany April 2010 Doctoral Thesis (“Summa cum laude”/1.0), Freiburg, Germany September 2009 German Medical Licence (Grade: 2.0), Freiburg, Germany October 2004 – May 2009 Clinical part of medical studies: Albert-Ludwigs University Freiburg, Germany; & Mount Sinai Medical School, New York, USA September 2004 Preliminary Medical Examination (Grade 2.3), Würzburg, Germany October 2002 – September 2004 Pre-Clinical part of medical studies: Julius-Maximilians-University Würzburg RESEARCH EXPERIENCE Mai 2004 - present Clinical studies (GCP), first PI: SEE-HF: 2014 October 2008 - present Clinical and basic research projects, University Heart Centers Freiburg-Bad Krozingen and Tübingen April 2005 – May 2009 Basic Research: Department of Experimental Anaesthesiology, Freiburg, Germany (Doctoral thesis) LANGUAGES German: Native speaker English: Advanced INTERESTS /MEMBERSHIPS Profesional: Valve surgery, CABG, Mechanical circulatory support, Thoracic Transplantation, Scientometrics, Hemocompatibility, Reperfusion, Apoptosis Personal: Mountaineering, Sailing, Cycling, Photography Member: International Society of Heart and Lung Transplantation (ISHLT), European Association of Cardiothoracic Surgery (EACTS), German Society of Thoracic and Cardiovacular Surgery (DGTHG)
Dr. Francesca Tinti MDHospital/Company: Sapienza University of RomeOffice City: RomeOffice Country: ItalyDr. Tinti was trained at Sapienza University of Rome, Italy, (supervisor Prof. Anna Paola Mitterhofer). The scientific activity carried out by Dr. Tinti has always proved to be strongly in line with the clinical activity. She has always directed her interest to transplantation of abdominal organs, in particular kidney transplantation and liver transplantation, initially in collaboration with the surgeons of the Sapienza Transplant Centre, and subsequently in international research and collaboration programs with the Liver Transplant Unit and the Renal Unit at Queen Elizabeth University Hospital (Birmingham, UK). Participation in kidney and liver transplantation was associated with the follow-up of patients pre- and post-transplantation. Particular attention was paid to immunosuppressive therapy and its complications in particular viral infections, nephrotoxicity and adverse cardiovascular effects, different immunosuppression schemes and innovative pharmacological formulations. Dr. Tinti has developed over time an increasing interest in acute and chronic renal dysfunction in liver transplantation, focusing to study patients in the immediate post-transplantation and in the long-term follow-up. She has also developed an interest in the study and follow-up of renal function in patients with hepatitis C virus (HCV) infection, particularly in the use of new antiretroviral drugs. Lately, particular attention has been paid to the study and application of perfusion and maintenance techniques of the transplanted organs, in particular in the context of donation from deceased donors due to cardiocirculatory death. She recently completed the Doctoral project in hepatology, focusing on the role of ischaemia-reperfusion injury after liver transplantation affecting local and remote organs, with the development of biliary complications and acute kidney injury. The clinical experience during these years led her to achieve the European Diploma in Transplantation Medicine (UEMS), which required certified documentation of continuous and extensive training in all areas of transplant medicine, with specific participation in the evaluation of candidates for transplantation and post-transplant patient follow-up. Awarded with the ESOT Grant Transplant Fellowship (2017), she was also awarded with the Euroliver Foundation Award (2015) and several Travel Grants by EASL and ERA-EDTA. Former Chair of the Young Professionals in Transplantation (ESOT), she has been recently allowed as member of the European Board of Transplant Medicine (UEMS) as liason with young European group of transplant professional.
Miss Caroline DUDREUILH MDHospital/Company: HENRI MONDOROffice City: CRETEILOffice Country: FranceI am a nephrologist with a special interest in immunology and transplantation. My passion for immunology and research led me to complete my medical degree with an intercalated research period enabling me to be awarded a bachelor of science in "Immunology" in addition to a national Master degree’s on the topic "Graft and Host Relation". My Master degree’s internship was hosted within the laboratory of Professor Dürrbach (Inserm unit U1014/UMR1197 "Stem cells, transplantation, immuno-regulation"). It was an opportunity for me to confirm my interest in research and strengthened my career goal; to become an academic nephrologist. Following my training in Tours and Paris (Clinical fellowship in Nephrology and Transplantation in Henri Mondor Hospital) I elected to apply for a position as a research assistant in the MRC Centre Transplantation (Kings College, London) in the group of Professor Lombardi, focusing on tolerance induction in transplantation trough adoptive transfer of regulatory T cells (Tregs). The lab is ideally situated within Guy’s Hospital, which has one of the largest transplantation programs in the UK and is internationally recognised as a centre of excellence, with a special expertise in transplantation for highly sensitised patients and ABO incompatible transplantation (Professor Dorling, Professor Mamode). The ESOT Transplant Fellowship is an incredible opportunity for me to improve my basic science knowledge within one of the top centre for transplant immunology worldwide, whilst working with some of the most experienced investigators in the field of transplant rejection and tolerance, with a particular focus on the contribution of the different subtypes of T and B cells.
Dr. Maria MeneghiniHospital/Company: IRCCS Cà Grande Ospedale Policlinico MilanoOffice City: MilanOffice Country: ItalyI am a medical doctor and I recently concluded my residency in Nephrology. During the 5 years of the residency program I had the possibility to practice in all areas of the nephrology specialization: clinical nephrology, management of acute and chronic kidney diseases, hemodialysis and peritoneal dialysis and, of course, kidney transplantation. I was particularly interested in this last topic and during the residency I could gain experience in the clinical management of kidney transplant patients both at Ospedale Policlinico in Milan and during a short clinical internship in Barcelona. The experience of the ESOT Transplant Fellowship would be the occasion to deepen my knowledge on kidney transplantation by having the chance of working one year in a European reference center where large numbers of all the most important types of kidney transplantation are performed. As the Spanish transplant system has recently been recognized as a very successful model by the international scientific community, the clinical experience in this center would be very useful for my future career. Moreover, in Italy some practices such as non-heart beating donors and ABO-incompatible transplantation are starting to grow in the last years, while in Spain a solid experience in such particular cases has already been developed. The approach to the management of transplant recipients both in the pre-transplant, early posttransplant and long term is similar in the two countries, being mostly assigned to the nephrologist. Therefore, an intensive training with the Bellvitge Kidney Transplant group would give me knowledge and skills to be used in Italy in the clinical setting.